Elevation of interleukin-10 levels in malignant pleural effusion

Chest

Volumn 110, Issue 2, 1996, Pages 433-436

  Chen, Yuh Min ^a,b   Yang, Wen Kuang ^a   Whang Peng, Jacqueline ^a   Kuo, Benjamin Ing Tian ^a   Perng, Reury Perng ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

helper T cell; interleukin 10; malignant pleural effusion; natural killer cell

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; BREAST CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HELPER CELL; HUMAN; LUNG CANCER; MALE; NATURAL KILLER CELL; PLEURA EFFUSION; PRIORITY JOURNAL; PROTEIN DETERMINATION; SUPPRESSOR CELL;

EID: 0029739957     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.110.2.433     Document Type: Article

References (22)

1. Sahn SA. The pleura. Am Rev Respir Dis 1988; 138:184-234
2. Light RW. Pleural diseases. Dis Mon 1992; 38:261-331
3. Weissler JC, Nicod LP, Toews GB. Pulmonary natural killer cell activity is reduced in patients with bronchogenic carcinoma. Am Rev Respir Dis 1987; 135:1353-57
4. Inoue Y, Shijulo N, Uede T. Induction of killer cells from lymphocytes in pleural effusion of advanced lung cancer patients. Jpn J Cancer Res 1990; 81:1012-20
5. Antony VB. Sahn SA. Mossman B, et al. Pleural cell biology in health and disease. Am Rev Respir Dis 1992; 145:1236-39
6. Shimokata K, Saka H, Murate T, et al. Cytokine content in pleural effusion - comparison between tuberculous and carcinomatous pleurisy. Chest 1991; 99:1103-07
7. Chehimi J, Trinchieri G. Interleukin-12: a bridge between innate resistance and adaptive immunity with a role in infection and acquired imnumodeficiency. J Clin Immunol 1994; 14:149-61
8. Allavena P, Paganin C, Zhou D, et al. Interlenkin-12 is chemotactic for natural killer cells and stimulates their interaction with vascular endothelium. Blood 1994; 84:2261-68
9. Gately MK. Interleukin-12: a recently discovered cytokine with potential for enhancing cell-mediated immune responses to tumors. Cancer Invest 1993; 11:500-06
10. Trinchieri G. Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 1994; 84:4008-27
11. Kennedy MK, Picha KS, Shanebeck KD, et al. Interlenkin-12 regulates the proliferation of Th1, but not Th2 or Th0, clones. Eur J Immunol 1994; 24:2271-78
12. Howard M, O'Garra A, Ishida H, et al. Biological properties of interleukin 10. J Clin Immnnol 1992; 12:239-47
13. Puri RK, Siegel JP. Interleukin-4 and cancer therapy. Cancer Invest 1993; 11:473-86
14. Takahashi K, Sone S, Kimura S, et al. Phenotypes and lymphokine-activated killer activity of pleural cavity lymphocytes of lung cancer patients without malignant effusion. Chest 1993; 103: 1732-38
15. Albera C, Mabritto I, Chio P, et al. Lymphocyte subpopulations analysis in pleural fluid and peripheral blood in patients with lymphocytic pleural effusions. Respiration 1991; 58:65-71
16. Lucivero G, Pierucci G, Bononio L. Lymphocyte subsets in peripheral blood and pleural fluid. Eur Respir J 1988; 1:337-40
17. Ribera E, Ocana I, Martinez-Vazqueze JM, et al. High level of interferon gamma in tuberenlous pleural effusion. Chest 1988; 93:308-11
18. Domagala W, Emeson EE, Koss LG. T and B lymphocyte enumeration in the diagnosis of lymphocyte-rich pleural fluids. Acta Cytol 1981; 25:108-10
19. + effectors. Br J Cancer 1994; 70:625-30
20. Okubo Y, Nakata M, Kuroiwa Y, et al. NK cells in carcinomatous and tuberculous pleurisy - phenotypic and functional analyses of NK cells in peripheral blood and pleural effusions. Chest 1987; 92:500-04
21. Zhang M, Gong J, Lyer DV, et al. T cell cytokine responses in persons with tuberculosis and human immunodeficiency virus infection. J Clin Invest 1994; 94:2435-42
22. Cassatellu MA, Meda L, Bonora S, et al. Interleukin 10 (IL-10) inhibits the release of proinflanimatory cytokines from human polymorphomiclear leukocytes: evidence for an autocrine role of tumor necrosis factor and IL-1β in mediating the production of IL-8 triggered by lipopolysaccharide. J Exp Med 1993; 178: 2207-11